Clinical association between pre-treatment levels of plasma fibrinogen and bone metastatic burden in newly diagnosed prostate cancer patients.

CONCLUSIONS: Pre-treatment plasma fibrinogen is positively associated with bone metastatic burden in PCa patients. Our results indicate that fibrinogen might be a potential predictor of HVD.
PMID: 31725446 [PubMed - as supplied by publisher]

Source: Chinese Medical Journal - November 11, 2019 Category: General Medicine Authors: Xie GS, Li G, Li Y, Pu JX, Huang YH, Li JH, Yin HM Tags: Chin Med J (Engl) Source Type: research